SecBot SecBot
← Back to Analyst Consensus
VYGR Buy

Voyager Therapeutics, Inc.

Current Price —
Implied Upside —
Analysts 17

30-Day Momentum

▲ 0 upgrades  /  ▼ 0 downgrades  /  0 reiterations  from 0 firms

Next Earnings

Nov 10, 2026 (14 days)

Rating Timeline

Date ▼FirmActionFrom → To RatingPrice TargetFirm Rating
Aug 10, 2026HC Wainwright & Co.reiterateBuy → Buy—44%
Mar 17, 2026HC Wainwright & Co.reiterateBuy → Buy—44%
Nov 12, 2025HC Wainwright & Co.maintainBuy → Buy$2544%
Sep 15, 2025HC Wainwright & Co.reiterateBuy → Buy$3044%
Aug 7, 2025WedbushmaintainOutperform → Outperform$858%
Apr 8, 2025HC Wainwright & Co.reiterateBuy → Buy$3044%
Mar 13, 2025Canaccord GenuitymaintainBuy → Buy$1248%
Mar 13, 2025HC Wainwright & Co.reiterateBuy → Buy$3044%
Mar 12, 2025Wells FargomaintainOverweight → Overweight$1054%
Mar 12, 2025WedbushreiterateOutperform → Outperform$058%
Mar 12, 2025Cantor FitzgeraldreiterateOverweight → Overweight$050%
Mar 3, 2025HC Wainwright & Co.reiterateBuy → Buy$3044%
Jan 27, 2025HC Wainwright & Co.reiterateBuy → Buy$3044%
Jan 10, 2025Cantor Fitzgeraldinitiate— → Overweight$5.7350%
Dec 2, 2024Citigroupinitiate— → Buy$1254%
Nov 14, 2024Canaccord GenuitymaintainBuy → Buy$1448%
Nov 14, 2024HC Wainwright & Co.reiterateBuy → Buy$3044%
Oct 24, 2024HC Wainwright & Co.reiterateBuy → Buy$3044%
Oct 16, 2024Leerink Partnersinitiate— → Outperform$1551%
Aug 20, 2024HC Wainwright & Co.reiterateBuy → Buy$3044%
Aug 7, 2024WedbushmaintainNeutral → Neutral$758%
Jul 31, 2024HC Wainwright & Co.reiterateBuy → Buy$3044%
May 16, 2024HC Wainwright & Co.reiterateBuy → Buy$3044%
May 15, 2024OppenheimermaintainOutperform → Outperform$1852%
May 14, 2024WedbushmaintainNeutral → Neutral$858%
Mar 26, 2024Guggenheiminitiate— → Buy$2252%
Mar 19, 2024HC Wainwright & Co.initiate— → Buy$3044%
Mar 7, 2024Citigroupinitiate— → Buy$1654%
Jan 2, 2024Wells FargoupgradeEqual-Weight → Overweight$1454%
Aug 7, 2023OppenheimerreiterateOutperform → Outperform$1652%
May 10, 2023Canaccord GenuitymaintainBuy → Buy$1448%
May 10, 2023Truist Securitiesinitiate— → Buy$1855%
Mar 10, 2023Oppenheimerinitiate— → Outperform$1452%
Nov 3, 2021Chardan Capitalmaintain— → Neutral$447%
Oct 7, 2021BairdupgradeNeutral → Outperform$955%
Apr 19, 2021Morgan Stanleymaintain— → Equal-Weight$654%
Feb 26, 2021BairddowngradeOutperform → Neutral$655%
Feb 3, 2021WedbushdowngradeOutperform → Neutral$658%
Feb 3, 2021Morgan Stanleymaintain— → Equal-Weight$754%
Feb 3, 2021BTIGdowngradeBuy → Neutral$052%
Nov 11, 2020OppenheimerdowngradeOutperform → Perform$052%
Nov 10, 2020Raymond JamesdowngradeStrong Buy → Outperform$1754%
Nov 10, 2020Wells FargodowngradeOverweight → Equal-Weight$1054%
Aug 4, 2020HC Wainwright & Co.maintain— → Buy$1444%
Apr 15, 2020Morgan Stanleymaintain— → Equal-Weight$1354%
Mar 30, 2020Nomuramaintain— → Buy$16—
Mar 19, 2020Benchmarkinitiate— → Buy$1854%
Mar 4, 2020HC Wainwright & Co.maintain— → Buy$1844%
Mar 4, 2020Morgan Stanleymaintain— → Equal-Weight$1454%
Mar 4, 2020Wedbushmaintain— → Outperform$2758%

Price Target Trend

Apr 3, 2026 Oct 27, 2026

EPS Estimates

0y —
+1y —
0q —
+1q —

Cross-Platform Signals

No cross-platform signals in the last 90 days

Fresh Analyst Detail

Price targets, earnings estimates, and firm actions for this ticker — updated within the last 24 hours.

Subscribe for Full Access